ALLAY PHARMACEUTICALS
DEAD

Serial Number

90542453

Owner

Allay Pharmaceuticals, LLC

Attorney

Mark C. Johnson

First Use Date

Jun 2, 2006

Filing Date

Feb 23, 2021

Add to watchlist:

No watchlists yet
View on USPTO

ALLAY PHARMACEUTICALS Trademark

Serial Number: 90542453

ALLAY PHARMACEUTICALS is a trademark filed by Allay Pharmaceuticals, LLC on February 23, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Allay Pharmaceuticals, LLC (16 trademarks)

16600 NW 54th Ave., Unit 23
Miami, FL 33014

Entity Type: 16

Trademark Details

Filing Date

February 23, 2021

Registration Date

Not Registered

First Use Anywhere

June 2, 2006

First Use in Commerce

June 2, 2006

Goods & Services

Alcohol for medicinal purposes; Antibiotic tablets; Antihypertensives; Antivirals; Enzyme preparations for medical purposes; Insulin; Medicinal herbal extracts for medical purposes; Medicinal preparations for the mouth and as sprays; Medicines for intestinal disorders; Natural supplements for treating candida; Natural supplements for treating depression and anxiety; Natural supplements for treating erectile dysfunction; Paracetamol; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceuticals for the treatment of erectile dysfunction; Prenatal vitamins; Preparation for the relief of pain; Sugar for medical purposes; Tumor suppressing agents

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 18, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 18, 2022 ABN2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 14, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 14, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 14, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 16, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2021 NWOS
NEW APPLICATION ENTERED
Feb 26, 2021 NWAP